R. Woods
Director/Board Member bei X4 PHARMACEUTICALS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Derzeit hat R. Keith Woods die Position des Chief Operating Officer der argenx SE inne. In seiner früheren Laufbahn hatte er die Position des SVP-North American Operations bei Alexion Pharmaceuticals, Inc. und des Vice President & Managing Director bei Alexion Pharma UK Ltd. (eine Tochtergesellschaft von Alexion Pharmaceuticals, Inc.). Er erhielt einen Bachelor-Abschluss von der Florida State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARGEN-X SE
0,01% | 20.02.2024 | 3 307 ( 0,01% ) | 1 Mio $ | 31.03.2024 |
X4 PHARMACEUTICALS, INC.
0,05% | 16.10.2023 | 90 000 ( 0,05% ) | 125 100 $ | 31.03.2024 |
Aktive Positionen von R. Woods
| Unternehmen | Position | Beginn |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Director/Board Member | 16.10.2023 |
| TSCAN THERAPEUTICS, INC. | Director/Board Member | 06.12.2023 |
| ROCKET PHARMACEUTICALS, INC. | Director/Board Member | 12.12.2023 |
Ehemalige bekannte Positionen von R. Woods
| Unternehmen | Position | Ende |
|---|---|---|
| ARGENX SE | Chief Operating Officer | 13.03.2023 |
Alexion Pharma UK Ltd.
 Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Part of AstraZeneca PLC, Alexion Pharma UK Ltd. is a pharmaceutical wholesaler founded in 2006. The private company is based in Middlesex, UK. | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von R. Woods
| Florida State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ARGENX SE | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Part of AstraZeneca PLC, Alexion Pharma UK Ltd. is a pharmaceutical wholesaler founded in 2006. The private company is based in Middlesex, UK. | Distribution Services |
